FSI is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has no current proprietary buy signal, no recent news catalyst, and fundamentals show weakening profitability in the latest quarter. While the analyst still has a Buy rating and the price target was reduced to $8.50, the current pre-market price of 6.32 already sits below that target, leaving limited immediate upside clarity. My direct view: hold off for now rather than buy immediately.
FSI is showing a mixed-to-neutral setup. MACD histogram is slightly positive at 0.0062 but contracting, which suggests momentum is fading rather than strengthening. RSI_6 at 42.691 is neutral and not oversold enough to indicate a strong rebound setup. Moving averages are converging, pointing to a sideways trend without clear breakout confirmation. Price is trading below the pivot at 6.572, with nearby support at 5.819 and resistance at 7.324. Overall, the chart does not show a decisive bullish trend at the current pre-market price of 6.32.
["Gross margin improved to 29.38% in the latest quarter, showing some operational efficiency improvement.", "Analyst William Gregozeski at Greenridge kept a Buy rating despite lowering the price target to $8.50.", "The analyst noted no long-term change in outlook, which suggests the business thesis is not broken."]
["No recent news in the past week, so there is no fresh event-driven catalyst.", "Revenue declined slightly year over year in 2025/Q4.", "Net income turned more negative year over year, and EPS also declined sharply.", "Hedge funds and insiders are both neutral, with no meaningful accumulation signal.", "No AI Stock Picker or SwingMax signal today.", "No recent congress trading data available."]
In 2025/Q4, revenue came in at 9,117,943, down 0.53% year over year. Net income fell to -460,926, worsening 167.82% year over year, and EPS declined to -0.04, down 180.00% year over year. The one bright spot was gross margin, which improved to 29.38%, up 0.72% year over year. Overall, the latest quarter shows weak earnings momentum despite better margin control.
Recent analyst sentiment is mildly positive but less aggressive than before. On 2026-04-23, Greenridge lowered its price target on Flexible Solutions to $8.50 from $11 while maintaining a Buy rating, citing delays in ramping up the January 2025 food contract and production shifts in legacy NCS products. Wall Street is therefore still constructive, but the reduced target and the lack of near-term catalysts make the pros view cautious rather than strongly bullish.